文献速递免疫规划慢病防控与筛查

脂质过氧化标志物丙二醛是血液透析患者乙肝疫苗应答的独立决定因素

Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients.
PubMed 文献 · Vaccine · 2026-05-30

在70例已接种乙肝疫苗的血液透析患者中,评估氧化应激标志物丙二醛(MDA)和晚期氧化蛋白产物、炎症标志物及免疫细胞活化标志物与抗-HBs抗体水平的关系。结果显示仅MDA与抗-HBs水平强相关(Rho=0.801,p<0.001),多因素回归中MDA为独立预测因子(B=92.71,p<0.001),提示脂质过氧化与疫苗应答独立相关。

要点

  • 血清MDA与血液透析患者抗-HBs抗体水平强相关(Rho=0.801)。
  • MDA是抗-HBs水平的独立预测因子(B=92.71,p<0.001)。
  • MDA可独立预测抗-HBs超过10 IU/L(OR 2.464)或100 IU/L(OR 7.767)。

核心结论

  • 血清MDA所反映的脂质过氧化与血液透析患者乙肝疫苗应答独立相关。

研究设计与样本

  • 在70例血液透析患者中评估抗-HBs抗体滴度、氧化应激标志物MDA和AOPP、炎症标志物CRP和中性粒细胞与淋巴细胞比值,以及中性粒细胞、T细胞和B细胞活化标志物钙卫蛋白、可溶性CD25和可溶性CD23,并记录人口学和临床数据。

主要发现

  • 仅MDA与抗-HBs抗体水平强相关(Rho=0.801,p<0.001)。
  • 多因素回归中MDA是抗-HBs水平的独立预测因子(B系数=92.71;p<0.001)。
  • 抗-HBs低于或高于10 IU/L的患者MDA水平不同(3.009(1.631-4.101)vs. 4.174(1.903-14.771)nmol/mL,p<0.001)。
  • 抗-HBs低于或高于100 IU/L的患者MDA水平不同(3.183(1.631-4.512)vs. 5.287(2.859-14.771)nmol/mL,p<0.001)。
  • 二元logistic回归证实MDA是抗-HBs超过10 IU/L(OR 2.464,p<0.001)或100 IU/L(OR 7.767,p<0.001)的独立预测因子。

临床怎么用

  • 在血液透析患者接种乙肝疫苗时,可关注血清MDA水平以辅助评估疫苗应答可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemodialysis (HD) patients demonstrate impaired adaptive immune function, as evidenced by reduced vaccine responses. Chronic inflammation, aberrant lymphocyte activation, and increased oxidative stress have all been implicated. We investigated the associations of markers of chronic inflammation, lymphocyte activation, and oxidative stress and the levels of antibodies against hepatitis B surface antigen (anti-HBs Ab) in vaccinated HD patients. METHODS: In 70 HD patients, anti-HBs Ab titers, oxidative stress markers malondialdehyde (MDA) and advanced oxidation protein products (AOPP), inflammatory markers CRP and neutrophil-to-lymphocyte ratio, and neutrophil, T-cell, and B-cell activation markers calprotectin, soluble CD25, and soluble CD23 were assessed, along with routine laboratory tests. Patients' demographic and clinical data were also recorded. RESULTS: Unexpectedly, only MDA was strongly correlated with anti-HBs Ab levels (Rho = 0.801, p < 0.001). In multivariable regression, MDA remained an independent predictor of anti-HBs Ab levels (B coefficient = 92.71; p < 0.001). Furthermore, MDA levels differed between patients with anti-HBs Ab levels below or above 10 IU/L (3.009 (1.631-4.101) vs. 4.174 (1.903-14.771) nmol/mL, p < 0.001) or 100 IU/L (3.183 (1.631-4.512) vs. 5.287 (2.859-14.771) nmol/mL, p < 0.001). Binary logistic regression confirmed that MDA is an independent predictor of anti-HBs Ab levels exceeding 10 IU/L (odds ratio 2.464, p < 0.001) or 100 IU/L (odds ratio 7.767, p < 0.001). CONCLUSION: Lipid peroxidation, as indicated by serum MDA, is independently associated with the response to hepatitis B vaccination in HD patients. Future studies should investigate whether preserved redox-dependent immune signaling may underlie effective vaccine responses in HD.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Divani M, Katsanaki A, Poulianiti C, et al. Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients. Vaccine. 2026. PMID: 42217446. doi:10.1016/j.vaccine.2026.128776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。